VGI Health Technology Limited (NSX:VTL) R & D Facility Agreement with Fundsquire Pty Ltd
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into an R&D Loan Facility Agreement (Loan Facility) with Fundsquire Pty Ltd.
Companies in the News
Clinical Trials
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH Phase II Clinical Study
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has commenced dosing of patients for its Phase II clinical study in Non-Alcoholic Fatty Liver Disease.
VGI Health Technology Limited (NSX:VTL) Receives Ethics Approval for US Clinical Study
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received ethics approval to proceed with a US pharmacokinetics and exercise clinical study.
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has made significant progress in its Phase II clinical study in Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic SteatoHepatitis (NASH).
VGI Health Technology Limited (NSX:VTL) June 2022 Quarterly Update
The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 30 June 2022.
VGI Health Technology Limited (NSX:VTL) Clinical Study Begins Recruitment of Patients
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd, has commenced recruitment of patients for its Phase II clinical study in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic SteatoHepatitis.
VGI Health Technology Limited (NSX:VTL) Binding Sale Agreement of Subsidiary
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has today executed a binding agreement for the sale of its wholly owned subsidiary Invictus BioPharma Pty Ltd.
◂Previous Page
Clinical Trials Next Page▸
Banking & Finance
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Annual Results
- Beetaloo Energy Australia Limited (ASX:BTL) Half Year Financial Report
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Operations Update
- Desert Mountain Energy Corp. (CVE:DME): Natural Gas, AI Data Centers & Helium - The New Mexico Advantage
- TMK Energy Limited (ASX:TMK) LF-07 Pilot Production Gas Well Update
- Beetaloo Energy Australia Limited (ASX:BTL) SEAAOC Darwin 2025 Presentation
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) Esophageal Cancer Test Results Presented at World Congress
- Proteomics International Laboratories Ltd (ASX:PIQ) Granted ISO Certification for Diagnostics Laboratory
- Proteomics International Laboratories Ltd (ASX:PIQ) Board and Management Transition
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEso Precisely Detects Early Stage Esophageal Cancer
- BPH Energy Limited (ASX:BPH) Annual Financial Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Preliminary Final and Annual Report
Social Media
